NCT01561456 |
|
Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung
|
View
|
NCT03572634 |
|
Phase 12 Study of TP-0903 an Inhibitor of AXL Kinase in Patients With Previously Treated CLL
|
View
|
NCT02729298 |
|
First-in-human Study of Oral TP-0903 a Novel Inhibitor of AXL Kinase in Patients With Advanced Solid Tumors
|
View
|
NCT03425201 |
|
Niraparib in Combination With Cabozantinib XL184 in Patients With Advanced Urothelial Cancer NICARAGUA
|
View
|
NCT03536208 |
|
Biological Effect of Warfarin on Pancreatic Cancer
|
View
|
NCT03965494 |
|
AXL Inhibitor BGB324 in Treating Participants With Recurrent Glioblastoma Undergoing Surgery
|
View
|
NCT04322630 |
|
Mer-TK in Human Cardiac Cells
|
View
|
NCT05346536 |
|
Liquid Biopsy and Pancreas Cancer Detection of AXL CTCs CTC-AXL-PANC
|
View
|
NCT05551715 |
|
Virtual Eye Model System for Personalised Refractive Surgery Treatment
|
View
|
NCT04316182 |
|
Cabozantinib in Patients With Hepatocellular Carcinoma ACTION
|
View
|
NCT01639508 |
|
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes ROS1 or NTRK Fusions or Increased MET or AXL Activity
|
View
|
NCT04458259 |
|
Study of PF-07265807 in Participants With Metastatic Solid Tumors
|
View
|
NCT00697632 |
|
Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies
|
View
|
NCT00785278 |
|
Adjusting Wheelchair Set-Up to Minimize Shoulder Joint Forces During Propulsion
|
View
|
NCT02219711 |
|
Phase 11b Study of MGCD516 in Patients With Advanced Cancer
|
View
|
NCT01062620 |
|
A Dose Escalating Clinical Trial of the IGF-1 Receptor Inhibitor AXL1717 in Patients With Advanced Cancer
|
View
|
NCT01139333 |
|
Blood and Tumor Tissue Samples From Young Patients With Acute Myeloid Leukemia
|
View
|
NCT03454243 |
|
Oral Immunomodulatory Tyrosine Kinase Inhibitor in Patients With Locally Advanced or Metastatic Solid Tumors
|
View
|
NCT03393936 |
|
Safety and Efficacy of CCT301 CAR-T in Adult Subjects With Recurrent or Refractory Stage IV Renal Cell Carcinoma
|
View
|
NCT05389462 |
|
A Study of Mipasetamab Uzoptirine ADCT-601 in Participants With Solid Tumors
|
View
|
NCT03522142 |
|
A Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Malignancies
|
View
|
NCT02424617 |
|
A Study of BGB324Bemcentinib in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer
|
View
|
NCT02488408 |
|
A Phase IbII Multicenter Open-label Study of Bemcentinib BGB324 in Patients With AML or MDS
|
View
|
NCT05740917 |
|
To Evaluate the Phase I Clinical Study of XZB-0004 in Patients With AML and MDS
|
View
|
NCT03990454 |
|
Safety Study of SLC-391 in Subjects With Solid Tumors
|
View
|
NCT02988817 |
|
Enapotamab Vedotin HuMax-AXL-ADC Safety Study in Patients With Solid Tumors
|
View
|
NCT03176277 |
|
A Study of ONO-7475 in Patients With Acute Leukemias
|
View
|
NCT04600219 |
|
The Effect of Tyrosine Kinase Receptor Axl on Dialysis Prognosis in Chronic Hemodialysis Patients
|
View
|
NCT03396003 |
|
A Comparison of Two Devices for Taking Measurements of the Eye to Assist in Lens Selection for Cataract Surgery
|
View
|
NCT03425279 |
|
CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma
|
View
|
NCT04681131 |
|
CAB-AXL-ADC Safety and Efficacy Study in Adults with NSCLC
|
View
|
NCT03649321 |
|
Clinical Trial of Chemotherapy and Bemcentinib for Metastatic Pancreatic Cancer
|
View
|
NCT06359847 |
|
Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer
|
View
|
NCT03769311 |
|
Cetuximab in Head and Neck Cancer Patients
|
View
|
NCT03824080 |
|
Evaluating the Efficacy and Safety of Bemcentinib in Patients With Myelodysplastic Syndromes
|
View
|
NCT04004442 |
|
Avelumab in Combination With AVB-S6-500 in Patients With Advanced Urothelial Carcinoma
|
View
|
NCT04045626 |
|
Study of Demarcation Line Depth in Transepithelial Versus Epithelium-off Accelerated Cross-linking AXL in Keratocouns
|
View
|
NCT04042623 |
|
Study of Safety and Efficacy of AVB-S6-500 in Patients With IgA Nephropathy
|
View
|
NCT05410717 |
|
CLDN6GPC3MesothelinAXL-CAR-NK Cell Therapy for Advanced Solid Tumors
|
View
|
NCT05860296 |
|
Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug Pembrolizumab for Advanced Lung Cancers
|
View
|
NCT04895215 |
|
AB-2004 in Treatment of Irritability Associated With Autism Spectrum Disorder ASD
|
View
|
NCT05128786 |
|
CCT301-38 CAR-T in Patients With Relapsed or Refractory AXL Positive Sarcomas
|
View
|
NCT02034981 |
|
Phase 2 Study Assessing Efficacy and Safety of Crizotinib in Patients Harboring an Alteration on ALK MET or ROS1
|
View
|
NCT05772455 |
|
A Study of XZB-0004 in Patients With Solid Tumors
|
View
|
NCT05816785 |
|
Pilot Study of Imatinib Cetuximab Combo for H N Cancer
|
View
|
NCT00949143 |
|
Effects of Axle Positions on Wheelchair Skills in Manual Wheelchair Users
|
View
|
NCT01014468 |
|
Bevacizumab Versus Ranibizumab in Age Related Macular Degeneration
|
View
|
NCT06049667 |
|
A Phase 1 Clinical Trail of NTQ2494 Tablets in Patients With Advanced Hematological Malignancies
|
View
|
NCT06231550 |
|
A Study of Axl Inhibitor FC084CSA in Patients With Advanced Malignant Solid Tumors
|
View
|
NCT06359860 |
|
A Study of ST-1898 for Unresectable or Metastatic Melanoma
|
View
|
NCT06499350 |
|
A Study of FC084CSA in Combination of Tislelizumab in Patients With Advanced Malignant Solid Tumors
|
View
|
NCT04129463 |
|
Subscleral Trabeculectomy With Iris Incarceration in Buphthalmous
|
View
|
NCT03198052 |
|
GPC3MesothelinClaudin182GUCY2CB7-H3PSCAPSMAMUC1TGFβHER2Lewis-YAXLEGFR-CAR-T Cells Against Cancers
|
View
|
NCT03607955 |
|
Paclitaxel Carboplatin With AVB-S6-500 in Women With Stage III or IV Epithelial Ovarian Primary Peritoneal or Fallopian Tube Cancer Receiving Neoadjuvant Chemotherapy
|
View
|